ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Intrinsic Value
Zhuzhou Qianjin Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. [ Read More ]
The intrinsic value of one
ZhuZhou QianJin Pharmaceutical Co Ltd
stock under the Base Case scenario is
12.31
CNY.
Compared to the current market price of 11.53 CNY,
ZhuZhou QianJin Pharmaceutical Co Ltd
is
Undervalued by 6%.
ZhuZhou QianJin Pharmaceutical Co Ltd's market capitalization is 4.8B CNY.
ZhuZhou QianJin Pharmaceutical Co Ltd stock price is 11.53 CNY.
ZhuZhou QianJin Pharmaceutical Co Ltd stock price (11.53 CNY) is 6% less than its Intrinsic Value (12.31 CNY).
ZhuZhou QianJin Pharmaceutical Co Ltd stock price (11.53 CNY) is 13% less than its DCF Value (13.18 CNY). Open DCF Valuation
ZhuZhou QianJin Pharmaceutical Co Ltd stock (11.43 CNY) is 1% less than its price (11.53 CNY). Open Relative Valuation
ZhuZhou QianJin Pharmaceutical Co Ltd has upside potential of 32% compared to the average analyst price target.
Open Wall St Estimates
ZhuZhou QianJin Pharmaceutical Co Ltd has positive Operating Income for the last twelve months.
ZhuZhou QianJin Pharmaceutical Co Ltd's Revenue has grown by 1% over the past 12 months.
ZhuZhou QianJin Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 14% to 14%.
ZhuZhou QianJin Pharmaceutical Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 13% to 15%.
ZhuZhou QianJin Pharmaceutical Co Ltd's Revenue has been growing by 3% per year for the last 3 years.
ZhuZhou QianJin Pharmaceutical Co Ltd has positive Net Income for the last twelve months.
ZhuZhou QianJin Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 14%.
ZhuZhou QianJin Pharmaceutical Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
ZhuZhou QianJin Pharmaceutical Co Ltd has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
ZhuZhou QianJin Pharmaceutical Co Ltd has positive three-year average ROIC (Return on Invested Capital): 14%. The company is efficient at using invested capital to generate operating income.
ZhuZhou QianJin Pharmaceutical Co Ltd has positive Free Cash Flow for the last twelve months.
ZhuZhou QianJin Pharmaceutical Co Ltd's long-term assets (4B CNY) exceed its long-term liabilties (2B CNY).
ZhuZhou QianJin Pharmaceutical Co Ltd's Altman Z-Score is very high and is equal to 3.12.
ZhuZhou QianJin Pharmaceutical Co Ltd has positive Gross Profit for the last twelve months.
ZhuZhou QianJin Pharmaceutical Co Ltd's short-term assets (3B CNY) exceed its short-term liabilties (1B CNY).
ZhuZhou QianJin Pharmaceutical Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (1B CNY) than debt (524m CNY).
ZhuZhou QianJin Pharmaceutical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.24.
Valuation Backtest
ZhuZhou QianJin Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling
ZhuZhou QianJin Pharmaceutical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
ZhuZhou QianJin Pharmaceutical Co Ltd
Balance Sheet Decomposition
ZhuZhou QianJin Pharmaceutical Co Ltd
| Current Assets | 3.3B |
| Cash & Short-Term Investments | 1.5B |
| Receivables | 1.1B |
| Other Current Assets | 741.1m |
| Non-Current Assets | 1.1B |
| Long-Term Investments | 186.7m |
| PP&E | 622.3m |
| Intangibles | 234.2m |
| Other Non-Current Assets | 49.6m |
| Current Liabilities | 1.5B |
| Accounts Payable | 355.6m |
| Accrued Liabilities | 102.1m |
| Short-Term Debt | 490.6m |
| Other Current Liabilities | 530.9m |
| Non-Current Liabilities | 686.1m |
| Long-Term Debt | 33.7m |
| Other Non-Current Liabilities | 652.4m |
Earnings Waterfall
ZhuZhou QianJin Pharmaceutical Co Ltd
|
Revenue
|
3.9B
CNY
|
|
Cost of Revenue
|
-2.2B
CNY
|
|
Gross Profit
|
1.7B
CNY
|
|
Operating Expenses
|
-1.3B
CNY
|
|
Operating Income
|
409m
CNY
|
|
Other Expenses
|
-95.6m
CNY
|
|
Net Income
|
313.4m
CNY
|
Free Cash Flow Analysis
ZhuZhou QianJin Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
ZhuZhou QianJin Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
ZhuZhou QianJin Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
ZhuZhou QianJin Pharmaceutical Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
ZhuZhou QianJin Pharmaceutical Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
ZhuZhou QianJin Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
ZhuZhou QianJin Pharmaceutical Co Ltd
is 15.22 CNY
.
Shareholder Return
Price
ZhuZhou QianJin Pharmaceutical Co Ltd
| Average Annual Return | 9.91% |
| Standard Deviation of Annual Returns | 46.16% |
| Max Drawdown | -40% |
| Market Capitalization | 4.8B CNY |
| Shares Outstanding | 428 916 992 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
ZhuZhou QianJin Pharmaceutical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Zhuzhou Qianjin Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Zhuzhou, Hunan and currently employs 4,975 full-time employees. The company went IPO on 2004-03-12. The firm's main products include tablets, granules, pills, hard capsules, syrups, herbs, vinum and gels, among others. The firm is also involved in the businesses of cultural entertainment, logistics and distribution, as well as the provision of hygienic products.
Contact
IPO
Employees
Officers
The intrinsic value of one
ZhuZhou QianJin Pharmaceutical Co Ltd
stock under the Base Case scenario is
12.31
CNY.
Compared to the current market price of 11.53 CNY,
ZhuZhou QianJin Pharmaceutical Co Ltd
is
Undervalued by 6%.
You don't have any saved screeners yet
